Revenue Performance - Total revenue for the three months ended September 30, 2024, was 256.6million,adecreaseof12.2292.3 million for the same period in 2023[80]. - Product revenue was 246.8million,or96.2283.4 million, or 96.9% of total revenue, for the three months ended September 30, 2023, reflecting a decrease of 36.5million[81].−Servicesrevenueincreasedto9.7 million, or 3.8% of total revenue, compared to 9.0million,or3.1765.4 million, a decrease of 6.7% compared to 820.3millionforthesameperiodin2023[80].−ProductrevenuefortheninemonthsendedSeptember30,2024,was735.6 million, or 96.1% of total revenue, down from 795.0million,or96.929.8 million, or 3.9% of total revenue, compared to 25.3million,or3.1110.4 million, a decrease of 14.1% from 128.6millionforthesameperiodin2023[88].−Thegrossmarginfromproductrevenuewas44.763.1 million, an increase of 5.1millionor8.758.0 million for the same period in 2023[91]. - Research and development expenses were 26.4millionforthethreemonthsendedSeptember30,2024,up2.3 million or 9.6% from 24.1millioninthesameperiodof2023[94].−Personnelcostsrepresented35.5 million or 56.3% of total operating expenses for the three months ended September 30, 2024, compared to 34.8millionor60.016.8 million for the three months ended September 30, 2024, a rise of 0.3millionor2.116.5 million in the same period of 2023[97]. - General and administrative expenses were 19.9millionforthethreemonthsendedSeptember30,2024,anincreaseof2.4 million or 13.8% compared to 17.4millionforthesameperiodin2023[100].OtherFinancialMetrics−OtherincomeforthethreemonthsendedSeptember30,2024,was8.5 million, compared to 2.0millionforthesameperiodin2023,reflectinga6.5 million increase[103]. - Income tax provision decreased to 6.8millionforthethreemonthsendedSeptember30,2024,down0.9 million or 12.3% from 7.7millioninthesameperiodof2023[104].−DeferredrevenueatSeptember30,2024,was164.0 million, down from 210.9millionatDecember31,2023[82].−Thecompany′stenlargestcustomersaccountedfor48.2128.0 million, compared to 91.3millionforthesameperiodin2023,representinganincreaseof40.2117.8 million, compared to 74.2millionin2023,reflectinga58.67.5 million, down from 10.5millionin2023,indicatingadecreaseof28.656.6 million, compared to 53.2millionin2023,showinganincreaseof6.445.4 million during the first nine months of 2024, up from 37.5millionin2023,whichisa21.1120.1 million in unrestricted cash and cash equivalents and 459.3millioninshort−terminvestments[107].−AsofSeptember30,2024,thecompanyhadasecuritydepositof5.9 million related to the lease of its corporate headquarters, classified as long-term restricted cash[112]. - The company believes that its existing cash and cash equivalents will be sufficient to meet anticipated cash requirements for both the short- and long-term[112]. - There have been no material changes to the quantitative information about market risk as of September 30, 2024, compared to disclosures in the 2023 Form 10-K[114].